From the publishers of JADPRO
Multiple Myeloma
Resource Center
Menu
Resources
Videos
Videos
Quizzes
News & Literature Highlights
Case Studies
Advertisement
Test your knowledge to see how well you remember our 2025 Resource Center
Last Updated: Wednesday, January 21, 2026
Loading...
Advertisement
News & Literature Highlights
Cell Communication and Signaling
CAR-NK cell therapy in multiple myeloma: From preclinical and clinical landscape to joining the force for treatment strategies optimization
Clinical and Experimental Medicine
Clinical outcomes and safety of CD47-targeted immunotherapies across hematologic malignancies: A systematic review of monoclonal antibodies and fusion proteins in combination strategies
European Journal of Haematology
Prognostic impact of the Hevylite Assay in patients with IgG or IgA multiple myeloma treated within the GMMG-MM5 trial
Blood Reviews
Redefining central nervous system multiple myeloma: From rare phenomenon to emerging entity
Supportive Care in Cancer
Symptom distress and fear of progression associated with quality of life in multiple myeloma patients receiving treatment
Frontiers in Oncology
Post-progression outcomes following BCMA-directed CAR T-cell therapy in myeloma: Impact of extramedullary and paramedullary disease
Leukemia & Lymphoma
Treatment response assessment using whole body diffusion weighted-magnetic resonance imaging in myeloma: A retrospective cohort study
BMC Pulmonary Medicine
Evaluating pre-transplant nutritional indices as predictors of pneumonia and mortality in multiple myeloma patients post-autologous stem cell transplantation
European Journal of Haematology
From trials to practice: A 2025 review of idecabtagene vicleucel and ciltacabtagene autoleucel efficacy across clinical studies and real-world evidence
Advances in Hematology
Newly diagnosed high-risk multiple myeloma: Outcomes and management
Advertisement
Case Studies
Functional High-Risk Multiple Myeloma
Linvoseltamab in Relapsed/Refractory Multiple Myeloma
Relapsed Multiple Myeloma Treated with Teclistamab
Advertisement
Quizzes
Test your knowledge to see how well you remember our 2025 Resource Center
Test your knowledge of functional high-risk multiple myeloma
Test your knowledge of linvoseltamab in relapsed/refractory multiple myeloma